Despite advances in the prevention and treatment of fragility fractures, their prevalence continues to grow. The identification and treatment of osteoporosis in these high-risk patients are widely reported to be inadequate. The results of the 2002 and 2006 "Orthopaedic Surgeon Survey" under the auspice of BJD and IOF have shown a better involvement of the orthopaedic surgeon in osteoporosis management during his routine clinical practice. The orthopaedic surgeons knew that fragility fractures in patient over 50 years old require investigation for osteoporosis. Although some surgeons agreed to initiate investigation and inform patient about new osteoporosis fracture risk, the majority did not institute medical treatment and thought that the patient primary care provider or rheumatologist should be responsible for medical care. This round table highlights the current aspect of management of fragility fractures and focuses on diagnosis imaging techniques, pharmacological treatment as well as recent advances in implant design and surgical techniques.